Type 2 & other diabetes

Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore

Lancet Diabetes EndocrinolPublished Cross-sectional study

Authors' conclusion

Visceral adiposity is an independent risk factor for metabolic disease in Asian populations, and accounts for a large fraction of type 2 diabetes cases in each of the ethnic groups studied. However, the variation in insulin resistance and type 2 diabetes risk between Asian subgroups is not consistently explained by adiposity, indicating an important role for additional mechanisms underlying the susceptibility to cardiometabolic disease in Asian populations.

Study context

Population
Multiethnic Asian men and women living in Singapore, aged 30–84 years, HELIOS cohort, with DXA body composition and metabolic characterisation; mean age 52.8 years, 59.6% femaleof 10,004 consented
Participants
9,067 men
Exposure
Asian ethnic subgroups (Malay, Indian vs Chinese); BMI and visceral fat mass index (vFMI) vs cardiometabolic outcomes
  • Chinesen = 6,224reference
  • Malayn = 1,169
  • Indiann = 1,674
Outcome
Prevalence of T2D, hypercholesterolaemia and hypertension
Methodological detailspopulation-based cohort (HELIOS), multiethnic, DXA body composition, multivariable regression, Between April 2, 2018, and Jan 28, 2022
  • Population-based cohort (HELIOS)
  • Multiethnic
  • DXA body composition
  • Multivariable regression
  • Between April 2, 2018, and Jan 28, 2022

Main finding

As reported in the abstract

T2D prevalence
8.2% (n=744)
Hypercholesterolaemia prevalence
27.2% (n=2469)
Hypertension prevalence
18.0% (n=1630)
Malay and Indian vs Chinese participants: odds of obesity and T2D
3-4-times higher
Excess adiposity associated with adverse cardiometabolic health indices including T2D
p<0.0001

Observational data: associations, not effects.

Original publication

Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore. Lancet Diabetes Endocrinol. Published 29 August 2024. doi:10.1016/s2213-8587(24)00195-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.